Syncom Formulations (India) is currently trading at Rs. 3.69, up by 0.04 points or 1.10% from its previous closing of Rs. 3.65 on the BSE.
The scrip opened at Rs. 3.70 and has touched a high and low of Rs. 3.72 and Rs. 3.58 respectively. So far 4565173 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 4.00 on 12-Jan-2021 and a 52 week low of Rs. 0.39 on 13-Mar-2020.
Last one week high and low of the scrip stood at Rs. 4.00 and Rs. 3.58 respectively. The current market cap of the company is Rs. 286.50 crore.
The promoters holding in the company stood at 40.48% and Non-Institutions held 59.52%.
Syncom Formulations (India) has been awarded by IPF Industrial Excellence Awards, 2021 in Fastest Growing Companies - Pharma - Medium SMEs Category by IPF Industrial Excellence Forum and award have been declared on January 15, 2021.
Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry, engaged in the business of manufacturing, selling, distribution and marketing of pharmaceuticals.
